296 related articles for article (PubMed ID: 19679205)
1. Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.
Pereira RC; Juppner H; Azucena-Serrano CE; Yadin O; Salusky IB; Wesseling-Perry K
Bone; 2009 Dec; 45(6):1161-8. PubMed ID: 19679205
[TBL] [Abstract][Full Text] [Related]
2. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
Rowe PS
Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
[TBL] [Abstract][Full Text] [Related]
3. FGF-23 in bone biology.
Wesseling-Perry K
Pediatr Nephrol; 2010 Apr; 25(4):603-8. PubMed ID: 20012997
[TBL] [Abstract][Full Text] [Related]
4. Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
Imanishi Y; Hashimoto J; Ando W; Kobayashi K; Ueda T; Nagata Y; Miyauchi A; Koyano HM; Kaji H; Saito T; Oba K; Komatsu Y; Morioka T; Mori K; Miki T; Inaba M
J Bone Miner Metab; 2012 Jan; 30(1):93-9. PubMed ID: 21739089
[TBL] [Abstract][Full Text] [Related]
5. Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients.
Pereira RC; Jüppner H; Gales B; Salusky IB; Wesseling-Perry K
PLoS One; 2015; 10(3):e0120856. PubMed ID: 25774916
[TBL] [Abstract][Full Text] [Related]
6. Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone.
Nampei A; Hashimoto J; Hayashida K; Tsuboi H; Shi K; Tsuji I; Miyashita H; Yamada T; Matsukawa N; Matsumoto M; Morimoto S; Ogihara T; Ochi T; Yoshikawa H
J Bone Miner Metab; 2004; 22(3):176-84. PubMed ID: 15108058
[TBL] [Abstract][Full Text] [Related]
7. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.
Martin A; David V; Laurence JS; Schwarz PM; Lafer EM; Hedge AM; Rowe PS
Endocrinology; 2008 Apr; 149(4):1757-72. PubMed ID: 18162525
[TBL] [Abstract][Full Text] [Related]
8. MEPE Localization in the Craniofacial Complex and Function in Tooth Dentin Formation.
Gullard A; Gluhak-Heinrich J; Papagerakis S; Sohn P; Unterbrink A; Chen S; MacDougall M
J Histochem Cytochem; 2016 Apr; 64(4):224-36. PubMed ID: 26927967
[TBL] [Abstract][Full Text] [Related]
9. FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation.
Kyono A; Avishai N; Ouyang Z; Landreth GE; Murakami S
J Bone Miner Metab; 2012 Jan; 30(1):19-30. PubMed ID: 21678127
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia.
Habra MA; Jimenez C; Huang SC; Cote GJ; Murphy WA; Gagel RF; Hoff AO
Endocr Pract; 2008 Dec; 14(9):1108-14. PubMed ID: 19158050
[TBL] [Abstract][Full Text] [Related]
11. A unified model for bone-renal mineral and energy metabolism.
Rowe PS
Curr Opin Pharmacol; 2015 Jun; 22():64-71. PubMed ID: 25880364
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.
Atkins GJ; Rowe PS; Lim HP; Welldon KJ; Ormsby R; Wijenayaka AR; Zelenchuk L; Evdokiou A; Findlay DM
J Bone Miner Res; 2011 Jul; 26(7):1425-36. PubMed ID: 21312267
[TBL] [Abstract][Full Text] [Related]
13. Calcium‑dependent activation of PHEX, MEPE and DMP1 in osteocytes.
Donmez BO; Karagur ER; Donmez AC; Choi J; Akkus O
Mol Med Rep; 2022 Dec; 26(6):. PubMed ID: 36281920
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast Growth Factor-23 and Matrix Extracellular Phosphoglycoprotein Levels in Healthy Children and, Pregnant and Puerperal Women.
Ozsen A; Furman A; Guran T; Bereket A; Turan S
Horm Res Paediatr; 2019; 92(5):302-310. PubMed ID: 32187608
[TBL] [Abstract][Full Text] [Related]
15. [Osteocyte and DMP1].
Toyosawa S; Oya K; Sato S; Ishida K
Clin Calcium; 2012 May; 22(5):713-20. PubMed ID: 22549196
[TBL] [Abstract][Full Text] [Related]
16. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.
Rowe PS; de Zoysa PA; Dong R; Wang HR; White KE; Econs MJ; Oudet CL
Genomics; 2000 Jul; 67(1):54-68. PubMed ID: 10945470
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of dentin matrix protein 1 (Dmp1) phosphorylation by Fam20C in bone: implications for the induction of biomineralization.
Oya K; Ishida K; Nishida T; Sato S; Kishino M; Hirose K; Ogawa Y; Ikebe K; Takeshige F; Yasuda H; Komori T; Toyosawa S
Histochem Cell Biol; 2017 Mar; 147(3):341-351. PubMed ID: 27614627
[TBL] [Abstract][Full Text] [Related]
18. Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells.
Zhang GX; Mizuno M; Tsuji K; Tamura M
Endocrine; 2004 Jun; 24(1):15-24. PubMed ID: 15249699
[TBL] [Abstract][Full Text] [Related]
19. Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motif.
Zelenchuk LV; Hedge AM; Rowe PS
Bone; 2015 Oct; 79():131-42. PubMed ID: 26051469
[TBL] [Abstract][Full Text] [Related]
20. Bone and heart health in chronic kidney disease: role of dentin matrix protein 1.
Martin A
Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):297-303. PubMed ID: 31107286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
